Acura Pharmaceuticals, Inc. , a specialty pharmaceutical company innovating abuse deterrent drugs, today announced that the company plans to report financial results for the first quarter of 2013 following ...
This Post sponsored by:
Inspetta: Proving complete consulting, marketing, advertising, software and product development services for business.
1-888-221-0106
Contribution by: Scott Leonard
See Scott Leonard's G+ Profile for more contributions.
Scott reminds you that this is an exerpt. Visit the publisher's link to read the full story.
Connect on Google+
Inspetta:
Connect on Facebook
Connect on Twitter
Connect on LinkedIn